The effects of Coptidis Rhizoma extract on a hypercholesterolemic animal model

Phytomedicine

Volumn 10, Issue 1, 2003, Pages 17-22

  Yokozawa, T ^a   Ishida, A ^a   Cho, E J ^a   Nakagawa, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Coptidis Rhizoma; Hypercholesterolemia; Oxidized LDL; Rat; Thiobarbituric acid reactive substance

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CHOLIC ACID; COPTIS RHIZOME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIET; DOSE RESPONSE; EXCRETION; FECES; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA; COPTIDIS; COPTIS;

EID: 0037285431     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/094471103321648610     Document Type: Article

References (37)

1. Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. AHA medical/scientific statement science advisory. Circulation 83: 356-362
2. Ballantyne CM (1998) Low-density lipoproteins and risk for coronary artery disease. Am J Cardiol 82: 3Q-12Q
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation 91: 2488-2496
4. Brown WV (2001) What are the priorities for managing cholesterol effectively? Am J Cardiol 88 (suppl): 21F-24F
5. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannenel WB (1986) Incidence of coronary heart disease and lipoprotein-cholesterol levels: the Framingham Study. JAMA 256: 2835-2838
6. Criqui MH, Golomb BA (1998) Epidemiologic aspects of lipid abnormalities. Am J Med 105: 48S-57S
7. Fukutake M, Yokota S, Kawamura H, Iizuka A, Amagaya S, Fukuda K, Komatsu Y (1998) Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biol Pharm Bull 21: 814-817
8. Gordon DJ, Rifkind BM (1989) High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 321: 1311-1316
9. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
10. Iizuka N, Miyamoto K, Hazama S, Yoshino S, Yoshimura K, Okita K, Fukumoto T, Yamamoto S, Tangoku A, Oka M (2000) Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett 158: 35-41
11. Kannel WB, Castelli WP (1979) Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study. Ann Intern Med 90: 85-91
12. Krieger M (1998) The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors. Proc Natl Acad Sci USA 95: 4077-4080
13. Kwiterovich PO (1997) The effect of dietary fat, antioxidants and pro-oxidants on blood lipids and lipoproteins and atherosclerosis. J Am Diet Assoc 97 (suppl): S31-S41
14. Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 332: 512-521
15. Lin HL, Liu TY, Lui WY, Chi CW (1999a) Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer 85: 1937-1942
16. Lin HL, Liu TY, Wu CW, Chi CW (1999b) Berberine modulates expression of mdr 1 gene product and the responses of digestive track cancer cells to paclitaxel. Br J Cancer 81: 416-422
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
18. Naito C, Yamanaka T (1978) Atherosclerosis and peroxidative lipid. Jpn J Geriatr 15: 187-191
19. 2+, and an anion-exchange resin. Clin Chem 24: 1504-1508
20. Noma A, Okabe H, Nakayama K, Ueno Y, Shinohara H (1979) Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins. Clin Chem 25: 1480-1481
21. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358
22. Otsuka H, Tsukui M, Matsuoka T, Goto M, Fujimura H, Hiramatsu Y, Sawada T (1974) Studies on anti-inflammatory agents. Anti-inflammatory screening by fertile egg method. Yakugaku Zasshi 94: 796-801
23. Ozaki Y (1995) Studies on anti-inflammatory effect of Japanese oriental medicines (Kampo medicines) used to treat inflammatory diseases. Biol Pharm Bull 18: 559-562
24. Peng WH, Haieh MT, Wu CR (1997) Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Jpn J Pharmacol 74: 261-266
25. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99: 1355-1362
26. Prasad K, Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 125: 958-973
27. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, Quiles JL, Baro L, Ramirez-Tortosa CL, Martinez-Victoria E, Gil A (1999) Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147: 371-378
28. Ribeiro Jorge PA, Neyra LC, Ozaki RM, Almeida E (1998) Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E. Atherosclerosis 140: 333-339
29. Ross R (1993) Update on atherosclerosis. Nature 362: 801-809
30. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, McNamara JR, Ordovas JM (1995) Lipoproteins, nutrition, aging, and atherosclerosis. Am J Clin Nutr 61 (suppl): 726S-740S
31. Schmeller T, Latz-Bruning B, Wink M (1997) Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defense against microorganisms and herbivores. Phytochemistry 44: 257-266
32. Stamler J, Wentworth D, Neaton JD (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828
33. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 320: 915-924
34. The expert panel (1988) Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148: 36-69
35. The expert panel (1993) Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269: 3015-3023
36. Witztum JL, Steinberg D (1991) Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792
37. Wu HL, Hsu CY, Liu WH, Yung BYM (1999) Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 81: 923-929